FDA Approves Sotyktu: A New Hope for Plaque Psoriasis Treatment
The Food and Drug Administration (FDA) has recently approved a new drug, Sotyktu, for the treatment of plaque psoriasis. This marks a significant milestone in the management of this chronic skin condition, which affects millions of people worldwide. In this … Continue reading FDA Approves Sotyktu: A New Hope for Plaque Psoriasis Treatment
